CE VIDEO: New Frontiers in Frontline Ocular Surface Care
Sponsored by Shire.
Speakers: Lyndon Jones, PhD, FCOptom, FAAO; Paul M. Karpecki, OD, FAAO; Kelly Nichols, OD, MPH, PhD, FAAO; Leslie O’Dell, OD, FAAO
February 16, 2018
February 28, 2019
On completion of this educational activity, optometrists should understand why a thorough exam of the ocular surface and adnexa are essential aspects of optometric care, and be able to perform a proper evaluation of the ocular surface that will provide more definitive diagnoses, as well as highlight new research on the inflammatory pathway and ocular surface disease treatments.
Lyndon Jones, PhD, FCOptom, FAAO; Paul M. Karpecki, OD, FAAO; Kelly Nichols, OD, MPH, PhD, FAAO; Leslie O’Dell, OD, FAAO
This course is COPE approved for 2 hours of CE credit. COPE ID is 56689-AS. Please check your state licensing board to see if this approval counts toward your CE requirement for relicensure.
This continuing education course is joint sponsored by the University of Alabama School of Optometry.
Dr. Jones is a consultant for Alcon, CooperVision and J&J Vision; and a principal investigator for Alcon, Allergan, CooperVision, GL Chemtech, J&J Vision, Nature’s Way, Novartis, Santen and Shire Pharmaceuticals.
Dr. Nichols is a consultant for Bruder Healthcare Company, InSite Vision, Parion Pharmaceuticals, SARcode Bioscience, Shire Pharmaceuticals, Sun Pharmaceuticals, Kala Pharmaceutical, Eleven Biotherapeutics, Science Based Health, Allergan, Santen Pharmaceutical.
Dr. Karpecki is a consultant for Aerie Pharmaceuticals, Alcon, Abbott Medical Optics, Akorn, Allergan, Anthem Bausch + Lomb, Bio-Tissue, BlephEx, Beaver-Visitec, Bruder Healthcare, Cambium Pharma, Essilor, Eyes4Lives, Focus Labs, Glaukos, iCare USA, Imprimis Pharmaceuticals, J&J, Konan Medical, Maculogix, Oasis, Ocular Therapeutix, Oculus, OcuSoft, Regeneron, SightRisk, Reichert, Shire Pharmaceuticals, Science Based Health, Smart Vision Labs, TearScience, Topcon, TLC Vision, Vision Care Inc., Vmax and Visiometrics; a research grant principal investigator for Eleven BioTherapeutics, Fera Pharmaceuticals, Shire Pharmaceuticals; has received honoraria for the speaker’s bureaus of Glaukos and Oculus; is director/clinical advisor for Optometric Medical Solutions; and is on the board of directors for TearLab.
Dr. O'Dell is a consultant to Eye Eco and Shire Pharmaceuticals; and a speaker for Allergan, Shire and Genyzme.
Watch this online distance learning course and click the link below to take the exam for 2 hours of CE credit.